Welcome to
On Feet Nation
blogshackers Online
Marvin Online
Felix Online
Selma Online
Theresa Online
harvey4ije Online
Alice Online
goditac499 Online
farhan Online
Posted by harvey4ije on July 19, 2024 at 11:25am 0 Comments 0 Likes
Posted by blogshackers on July 19, 2024 at 11:22am 0 Comments 0 Likes
When you dream of a perfect tropical getaway, Club Med Phuket stands out as an idyllic destination offering an unparalleled blend of luxury, adventure, and relaxation. Nestled on the picturesque coast of Thailand, this all-inclusive resort is renowned for its exceptional services and enchanting surroundings. In this article, we’ll explore why Club Med Phuket is the ultimate choice for your next vacation and what makes it a must-visit paradise.
Market Highlights
Carcinoembryogenic Antigen (CEA) Market is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.
In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the Carcinoembryonic Antigen market growth.
Increasing prevalence of cancer, rising healthcare expenditures, and developing diagnostic technologies will boost the global market during the forecast period. However, risk of infection and hematoma, lack of awareness and medical services in the developing countries will restrain the market growth during the assessment period.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/772
Market Key Players
Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.
Segmentation
The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.
Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others.
Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.
Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.
Regional Analysis
The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.
Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.
On account of the developing medical infrastructure, rising healthcare expenditure, and increasing government initiatives, Asia Pacific region is expected to grow the fastest.
Access Complete Report @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antig...
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation